Comella Kristin C 4
4 · U.S. Stem Cell, Inc. · Filed May 18, 2018
Insider Transaction Report
Form 4
Comella Kristin C
Chief Science Officer
Transactions
- Award
Stock Option (right to buy)
2018-05-07+10,000,000→ 30,697,746 totalExercise: $0.05Exp: 2028-05-07→ Common Stock (10,000,000 underlying)
Footnotes (1)
- [F1]2,500,000 vest on 05/07/2019, 2,500,000 vest on 05/07/2020, 2,500,000 vest on 05/07/2021, 2,500,000 vest on 05/07/2022.